Comment on

• Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.

  Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M, Fulton R, Schmidt H, Kalicki-Veizer J, O'Laughlin M, Kandoth C, Baty J, Westervelt P, DiPersio JF, Mardis ER, Wilson RK, Ley TJ, Graubert TA. Walter MJ, et al. Leukemia. 2011 Jul;25(7):1153-8. doi: 10.1038/leu.2011.44. Epub 2011 Mar 18. Leukemia. 2011. PMID: 21415852 Free PMC article.
• DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms.

  Abdel-Wahab O, Pardanani A, Rampal R, Lasho TL, Levine RL, Tefferi A. Abdel-Wahab O, et al. Leukemia. 2011 Jul;25(7):1219-20. doi: 10.1038/leu.2011.82. Epub 2011 Apr 26. Leukemia. 2011. PMID: 21519343 Free PMC article. No abstract available.
• DNMT3A mutations in myeloproliferative neoplasms.

  Stegelmann F, Bullinger L, Schlenk RF, Paschka P, Griesshammer M, Blersch C, Kuhn S, Schauer S, Döhner H, Döhner K. Stegelmann F, et al. Leukemia. 2011 Jul;25(7):1217-9. doi: 10.1038/leu.2011.77. Epub 2011 May 3. Leukemia. 2011. PMID: 21537334 No abstract available.